DOLUTEGRAVIR SODIUM

DOLUTEGRAVIR SODIUM was reported 9052 times

DOLUTEGRAVIR SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SUBEPENDYMAL CYST 7 0.6364
1 MYCOPLASMA GENITALIUM INFECTION 9 0.4737
2 BLOOD HIV RNA FLUCTUATION 4 0.4444
3 BLOOD HIV RNA 11 0.2115
4 CHOANAL STENOSIS 4 0.1667
5 CYSTOSTOMY 9 0.1607
6 ENDOMETRITIS DECIDUAL 6 0.1579
7 BONE DEMINERALISATION 160 0.1511
8 CONGENITAL UMBILICAL HERNIA 51 0.1367
9 ECTOPIC KIDNEY 11 0.1158
10 TEMPERATURE REGULATION DISORDER 252 0.1130
11 BIRTH MARK 23 0.1106
12 SCROTAL CYST 8 0.0941
13 CONGENITAL MELANOCYTIC NAEVUS 4 0.0889
14 BRAIN STEM HAEMATOMA 4 0.0870
15 GASTROENTERITIS ASTROVIRAL 6 0.0750
16 HORMONE-DEPENDENT PROSTATE CANCER 5 0.0714
17 DIABETES WITH HYPEROSMOLARITY 4 0.0690
18 BLOOD HIV RNA INCREASED 124 0.0683
19 PORTAL FIBROSIS 14 0.0654
20 FOETAL DEATH 332 0.0640
21 FEAR-RELATED AVOIDANCE OF ACTIVITIES 9 0.0592
22 CONGENITAL SKIN DIMPLES 13 0.0539
23 PELVIC KIDNEY 6 0.0517
24 VIRAL LOAD DECREASED 7 0.0479
25 RENAL DYSPLASIA 17 0.0439
26 FOOD ALLERGY 323 0.0418
27 TOTAL BILE ACIDS INCREASED 6 0.0411
28 MENINGOCELE 6 0.0382
29 HIV VIRAEMIA 8 0.0381
30 ANHEDONIA 945 0.0359
31 SYPHILIS 26 0.0358
32 CONGENITAL CEREBRAL CYST 4 0.0357
33 VIRAL LOAD ABNORMAL 6 0.0343
34 HYPERFERRITINAEMIA 14 0.0325
35 CYSTIC LYMPHANGIOMA 5 0.0289
36 CONGENITAL NAEVUS 4 0.0282
37 PLASMABLASTIC LYMPHOMA 10 0.0279
38 ANOGENITAL DYSPLASIA 4 0.0267
39 MENINGOMYELOCELE 16 0.0267
40 GENOTYPE DRUG RESISTANCE TEST POSITIVE 27 0.0263
41 FAT REDISTRIBUTION 6 0.0259
42 ECONOMIC PROBLEM 387 0.0255
43 MONKEYPOX 7 0.0254
44 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 125 0.0251
45 ACQUIRED IMMUNODEFICIENCY SYNDROME 13 0.0250
46 FANCONI SYNDROME ACQUIRED 44 0.0250
47 HYDROPS FOETALIS 15 0.0245
48 CD4 LYMPHOCYTES ABNORMAL 5 0.0238
49 THREATENED LABOUR 10 0.0233
50 IMMUNODEFICIENCY 343 0.0230
51 COELIAC DISEASE 213 0.0217
52 VIRAL LOAD INCREASED 84 0.0216
53 PULMONARY HYPOPLASIA 17 0.0216
54 PHARMACEUTICAL NOMADISM 11 0.0215
55 CEREBRAL AMYLOID ANGIOPATHY 7 0.0212
56 MACROCEPHALY 8 0.0206
57 PYROGLUTAMIC ACIDOSIS 8 0.0202
58 ANKYLOGLOSSIA CONGENITAL 8 0.0199
59 AORTA HYPOPLASIA 5 0.0192
60 OSTEOPENIA 290 0.0191
61 T-LYMPHOCYTE COUNT DECREASED 13 0.0191
62 HAEMANGIOMA CONGENITAL 9 0.0189
63 HAEMOPHILIA 4 0.0187
64 TUBERCULOSIS OF CENTRAL NERVOUS SYSTEM 5 0.0185
65 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 19 0.0179
66 BURSITIS 210 0.0173
67 CD4 LYMPHOCYTES INCREASED 4 0.0172
68 RENAL APLASIA 12 0.0171
69 HEPATIC ARTERY THROMBOSIS 5 0.0171
70 SINGLE FUNCTIONAL KIDNEY 11 0.0166
71 BONE METABOLISM DISORDER 5 0.0166
72 VAGINAL LESION 5 0.0163
73 LIPODYSTROPHY ACQUIRED 34 0.0160
74 PRESCRIBED OVERDOSE 299 0.0154
75 END STAGE RENAL DISEASE 277 0.0152
76 CENTRAL NERVOUS SYSTEM INFLAMMATION 5 0.0151
77 VERBAL ABUSE 7 0.0143
78 ENCEPHALOMALACIA 8 0.0142
79 STAB WOUND 5 0.0141
80 SUPERINFECTION BACTERIAL 11 0.0139
81 CONGENITAL HYDROCEPHALUS 7 0.0138
82 HIV INFECTION 41 0.0136
83 SENSATION OF BLOOD FLOW 5 0.0131
84 VIROLOGIC FAILURE 69 0.0128
85 BONE DENSITY DECREASED 400 0.0128
86 VIRAL MUTATION IDENTIFIED 47 0.0127
87 GLOMERULAR FILTRATION RATE ABNORMAL 18 0.0127
88 STILLBIRTH 60 0.0124
89 CD4 LYMPHOCYTES DECREASED 26 0.0121
90 ACUTE HEPATITIS B 4 0.0120
91 HYPERPARATHYROIDISM SECONDARY 30 0.0120
92 FOETAL EXPOSURE DURING DELIVERY 8 0.0118
93 ENTEROVIRUS INFECTION 10 0.0116
94 PNEUMOCOCCAL SEPSIS 7 0.0107
95 ANENCEPHALY 6 0.0106
96 EXPOSURE DURING PREGNANCY 655 0.0105
97 CALCULUS URINARY 16 0.0104
98 MENTAL DISABILITY 6 0.0104
99 OSTEOPOROSIS 426 0.0103
100 PRODUCT USE IN UNAPPROVED THERAPEUTIC ENVIRONMENT 9 0.0103
101 HEMIPARAESTHESIA 4 0.0103
102 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 11 0.0102
103 CHRONIC HEPATITIS C 4 0.0101
104 FOETAL GROWTH RESTRICTION 61 0.0100
105 SITTING DISABILITY 6 0.0097
106 TRISOMY 21 12 0.0095
107 LIPOATROPHY 9 0.0095
108 HEPATITIS A 8 0.0094
109 SKULL MALFORMATION 6 0.0093
110 CHRONIC KIDNEY DISEASE 703 0.0092
111 OSTEOMALACIA 14 0.0091
112 DEGENERATIVE BONE DISEASE 4 0.0090
113 FAECES PALE 20 0.0090
114 BONE DEFORMITY 6 0.0089
115 QUALITY OF LIFE DECREASED 119 0.0089
116 RENAL TUBULAR DYSFUNCTION 5 0.0088
117 EMOTIONAL DISTRESS 1051 0.0087
118 MENINGITIS CRYPTOCOCCAL 15 0.0086
119 DECREASED ACTIVITY 90 0.0083
120 NEURAL TUBE DEFECT 6 0.0083
121 PULMONARY ARTERY STENOSIS CONGENITAL 6 0.0082
122 NEPHROGENIC ANAEMIA 38 0.0082
123 MULTIPLE FRACTURES 134 0.0081
124 CONTRAINDICATED PRODUCT ADMINISTERED 238 0.0079
125 ATYPICAL MYCOBACTERIAL INFECTION 11 0.0078
126 CYTOMEGALOVIRUS CHORIORETINITIS 15 0.0077
127 PLACENTA PRAEVIA 6 0.0076
128 DELIVERY 5 0.0076
129 HIV TEST POSITIVE 5 0.0076
130 ABORTION INDUCED 71 0.0075
131 LIVE BIRTH 63 0.0075
132 ANAL ATRESIA 4 0.0075
133 PATHOGEN RESISTANCE 68 0.0075
134 BONE LOSS 111 0.0074
135 LEIOMYOMA 5 0.0072
136 NEPHROPATHY 67 0.0072
137 UPPER RESPIRATORY TRACT INFECTION 321 0.0069
138 DECREASED IMMUNE RESPONSIVENESS 68 0.0069
139 POLYDACTYLY 8 0.0069
140 TINEA PEDIS 11 0.0069
141 DYSLIPIDAEMIA 35 0.0069
142 HYPERPARATHYROIDISM 14 0.0068
143 FIBROCYSTIC BREAST DISEASE 5 0.0068
144 CENTRAL OBESITY 5 0.0068
145 RENAL TUBULAR DISORDER 19 0.0067
146 RASH ERYTHEMATOUS 319 0.0067
147 VITAMIN D DEFICIENCY 64 0.0066
148 CEREBRAL TOXOPLASMOSIS 6 0.0064
149 GLOMERULOSCLEROSIS 4 0.0063
150 OLIGOHYDRAMNIOS 21 0.0063
151 RENAL TUBULAR ACIDOSIS 13 0.0060
152 FOETAL EXPOSURE DURING PREGNANCY 483 0.0059
153 TOOTH LOSS 122 0.0059
154 NEUROTOXICITY 103 0.0059
155 MYCOTIC ALLERGY 5 0.0058
156 CORONAVIRUS TEST POSITIVE 6 0.0058
157 PROSTATIC OPERATION 7 0.0058
158 VASCULAR RUPTURE 9 0.0058
159 HAEMATOSPERMIA 4 0.0058
160 HEPATIC ENZYME INCREASED 388 0.0057
161 CONGENITAL HYDRONEPHROSIS 4 0.0056
162 MYCOBACTERIUM AVIUM COMPLEX INFECTION 15 0.0056
163 ANAEMIA OF CHRONIC DISEASE 5 0.0055
164 CHLAMYDIAL INFECTION 4 0.0053
165 PNEUMONIA CRYPTOCOCCAL 5 0.0053
166 GESTATIONAL DIABETES 25 0.0052
167 ARNOLD-CHIARI MALFORMATION 5 0.0052
168 GENITAL HERPES 8 0.0052
169 CEREBELLAR ATAXIA 5 0.0052
170 PERSECUTORY DELUSION 13 0.0052
171 CEREBRAL VENTRICLE DILATATION 6 0.0052
172 NEPHROGENIC DIABETES INSIPIDUS 6 0.0052
173 MULTIPLE-DRUG RESISTANCE 16 0.0052
174 FLUID RETENTION 259 0.0051
175 HAND FRACTURE 36 0.0051
176 ATRIAL SEPTAL DEFECT 42 0.0050
177 GLOMERULAR FILTRATION RATE DECREASED 61 0.0050
178 FOOT FRACTURE 94 0.0050
179 FANCONI SYNDROME 7 0.0049
180 SKELETAL INJURY 51 0.0049
181 SHOULDER FRACTURE 8 0.0049
182 OCULAR ICTERUS 21 0.0048
183 HEPATIC NECROSIS 18 0.0048
184 URETEROLITHIASIS 5 0.0048
185 OSTEONECROSIS 154 0.0047
186 PREMATURE SEPARATION OF PLACENTA 7 0.0045
187 INFUSION RELATED REACTION 298 0.0045
188 ANOGENITAL WARTS 4 0.0045
189 RHEUMATOID FACTOR INCREASED 5 0.0045
190 GLYCOSURIA 6 0.0044
191 HEPATITIS FULMINANT 13 0.0044
192 FOLATE DEFICIENCY 5 0.0043
193 RENAL IMPAIRMENT 362 0.0043
194 BONE DENSITY ABNORMAL 16 0.0043
195 BLOOD CREATININE INCREASED 277 0.0042
196 DISCOLOURED VOMIT 4 0.0042
197 PROTEINURIA 79 0.0042
198 FAT TISSUE INCREASED 6 0.0041
199 ANAL CANCER 4 0.0041
200 ABORTION SPONTANEOUS 165 0.0041
201 RENAL FAILURE 546 0.0041
202 TIBIA FRACTURE 19 0.0040
203 GASTRECTOMY 4 0.0040
204 RENAL TRANSPLANT 14 0.0039
205 GASTROSTOMY 6 0.0039
206 MATERNAL EXPOSURE DURING PREGNANCY 343 0.0038
207 HEPATITIS B 23 0.0038
208 PROTEIN URINE PRESENT 19 0.0038
209 DIABETES INSIPIDUS 9 0.0037
210 DRUG RESISTANCE 96 0.0037
211 ANXIETY 1060 0.0037
212 CLAUSTROPHOBIA 4 0.0037
213 BLOOD CREATINE INCREASED 16 0.0036
214 VIRAEMIA 5 0.0036
215 INTENTIONAL PRODUCT MISUSE 316 0.0036
216 WRIST FRACTURE 43 0.0036
217 CLEFT LIP AND PALATE 4 0.0036
218 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 172 0.0036
219 INTENSIVE CARE 5 0.0035
220 HEPATITIS CHOLESTATIC 21 0.0035
221 FIBULA FRACTURE 10 0.0035
222 RENAL INJURY 102 0.0034
223 GENERALISED ANXIETY DISORDER 5 0.0034
224 RADIUS FRACTURE 8 0.0033
225 THROMBOCYTOPENIA 368 0.0033
226 PATENT DUCTUS ARTERIOSUS 13 0.0033
227 HYPERPHOSPHATAEMIA 7 0.0033
228 HYPERTRIGLYCERIDAEMIA 19 0.0032
229 JAW FRACTURE 7 0.0032
230 DYSSTASIA 94 0.0032
231 AMPUTATION 4 0.0032
232 GASTROINTESTINAL TUBE INSERTION 8 0.0032
233 TREATMENT FAILURE 265 0.0032
234 BLOOD BICARBONATE DECREASED 6 0.0032
235 HYPERURICAEMIA 13 0.0032
236 CLAVICLE FRACTURE 12 0.0031
237 EXERCISE TOLERANCE DECREASED 18 0.0031
238 HEPATOSPLENOMEGALY 8 0.0031
239 DISINHIBITION 5 0.0031
240 LIPOMA 8 0.0031
241 HEPATITIS C 37 0.0031
242 HAEMANGIOMA 7 0.0030
243 SPINAL COMPRESSION FRACTURE 25 0.0030
244 LOW BIRTH WEIGHT BABY 24 0.0030
245 TOOTH INJURY 13 0.0030
246 INTRACRANIAL ANEURYSM 12 0.0030
247 LIPIDS INCREASED 6 0.0030
248 SPLEEN DISORDER 5 0.0029
249 PRE-ECLAMPSIA 14 0.0029
250 ASTHMA 331 0.0029
251 AGORAPHOBIA 4 0.0029
252 HYPOVOLAEMIC SHOCK 14 0.0029
253 JOINT SWELLING 351 0.0029
254 BENIGN PROSTATIC HYPERPLASIA 15 0.0029
255 PREMATURE RUPTURE OF MEMBRANES 7 0.0029
256 PAPILLARY THYROID CANCER 5 0.0029
257 GLUCOSE TOLERANCE IMPAIRED 17 0.0029
258 RIB FRACTURE 59 0.0029
259 CARDIOVERSION 4 0.0029
260 DRUG INTOLERANCE 275 0.0028
261 ANKLE FRACTURE 44 0.0028
262 HEPATITIS B REACTIVATION 9 0.0028
263 RHEUMATOID ARTHRITIS 320 0.0028
264 HYPERNATRAEMIA 14 0.0028
265 CARDIAC ABLATION 5 0.0028
266 HYPERHIDROSIS 355 0.0028
267 CHOLANGITIS 17 0.0027
268 RENAL PAIN 29 0.0027
269 PNEUMOCYSTIS JIROVECII PNEUMONIA 27 0.0027
270 RENAL TUBULAR NECROSIS 26 0.0026
271 INFECTED SKIN ULCER 5 0.0026
272 PERIARTHRITIS 6 0.0026
273 OSTEOPOROTIC FRACTURE 5 0.0026
274 BLOOD CREATININE ABNORMAL 9 0.0026
275 BLOOD URIC ACID INCREASED 15 0.0026
276 TALIPES 8 0.0026
277 PREMATURE DELIVERY 41 0.0026
278 PATELLA FRACTURE 6 0.0026
279 HYDROCEPHALUS 14 0.0026
280 DEPRESSIVE SYMPTOM 9 0.0026
281 LIVER TRANSPLANT 9 0.0025
282 GOITRE 10 0.0024
283 ACUTE PSYCHOSIS 6 0.0024
284 SPINA BIFIDA 5 0.0024
285 PAIN 1459 0.0024
286 CHOLESTASIS 45 0.0023
287 ACUTE SINUSITIS 4 0.0023
288 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 19 0.0023
289 PROSTATITIS 7 0.0023
290 GASTRIC BYPASS 5 0.0023
291 PROTEIN TOTAL INCREASED 6 0.0023
292 RETCHING 48 0.0022
293 STAPHYLOCOCCAL SEPSIS 11 0.0022
294 HYPERTENSION 468 0.0022
295 SOCIAL PROBLEM 9 0.0022
296 LYMPHOEDEMA 15 0.0022
297 NEPHROPATHY TOXIC 24 0.0021
298 SPLENOMEGALY 25 0.0021
299 ANTIPSYCHOTIC DRUG LEVEL INCREASED 6 0.0021
300 PRURITUS GENITAL 5 0.0021
301 TREATMENT NONCOMPLIANCE 115 0.0021
302 ACIDOSIS 16 0.0021
303 ACUTE KIDNEY INJURY 318 0.0021
304 PRODUCT USE ISSUE 390 0.0021
305 LYMPHADENITIS 5 0.0021
306 MUSCLE RUPTURE 8 0.0021
307 LUMBAR SPINAL STENOSIS 6 0.0021
308 SPINAL OSTEOARTHRITIS 18 0.0020
309 BRONCHITIS CHRONIC 5 0.0020
310 HEPATOMEGALY 20 0.0020
311 CERVICAL VERTEBRAL FRACTURE 7 0.0020
312 HYPERBILIRUBINAEMIA 21 0.0020
313 RENAL CYST 16 0.0020
314 HYPERLIPIDAEMIA 24 0.0020
315 LYMPHOMA 31 0.0020
316 PSORIASIS 259 0.0020
317 ENURESIS 8 0.0020
318 SHOCK HAEMORRHAGIC 16 0.0020
319 HYPERSENSITIVITY 364 0.0020
320 INTERVERTEBRAL DISC DEGENERATION 18 0.0019
321 FACIAL BONES FRACTURE 7 0.0019
322 LEG AMPUTATION 8 0.0019
323 POST-TRAUMATIC STRESS DISORDER 13 0.0019
324 RENAL FUNCTION TEST ABNORMAL 9 0.0019
325 SPINAL STENOSIS 8 0.0019
326 CHEST INJURY 4 0.0019
327 PREMATURE BABY 58 0.0019
328 UMBILICAL HERNIA 9 0.0019
329 HEPATITIS TOXIC 5 0.0019
330 FRACTURE 36 0.0019
331 HIP ARTHROPLASTY 29 0.0019
332 HEPATOTOXICITY 42 0.0019
333 HEPATIC PAIN 8 0.0019
334 POST PROCEDURAL INFECTION 15 0.0018
335 DUODENAL ULCER 13 0.0018
336 JAUNDICE 49 0.0018
337 DEPRESSION 409 0.0018
338 NEPHRITIS 6 0.0018
339 PSYCHOMOTOR RETARDATION 5 0.0018
340 DISEASE COMPLICATION 8 0.0017
341 VENTRICULAR SEPTAL DEFECT 10 0.0017
342 LEUKOPENIA 87 0.0017
343 TOOTH FRACTURE 19 0.0017
344 HEPATIC FUNCTION ABNORMAL 64 0.0017
345 PRODUCT USE COMPLAINT 27 0.0017
346 BLOOD CREATINE PHOSPHOKINASE INCREASED 49 0.0017
347 DYSMORPHISM 4 0.0017
348 IMPAIRED WORK ABILITY 36 0.0017
349 CONGENITAL ANOMALY 13 0.0017
350 LOWER LIMB FRACTURE 32 0.0017
351 INFECTION 241 0.0017
352 CEREBROVASCULAR DISORDER 5 0.0017
353 HUMERUS FRACTURE 8 0.0017
354 VARICES OESOPHAGEAL 5 0.0017
355 EMERGENCY CARE 5 0.0016
356 PULMONARY TUBERCULOSIS 7 0.0016
357 SKIN HYPERPIGMENTATION 14 0.0016
358 AMYLASE INCREASED 6 0.0016
359 FIBROSIS 5 0.0016
360 COAGULOPATHY 27 0.0016
361 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 4 0.0016
362 HYPERACUSIS 6 0.0016
363 IMMOBILE 7 0.0016
364 INVESTIGATION 5 0.0016
365 HIP FRACTURE 51 0.0016
366 IRIDOCYCLITIS 5 0.0016
367 BLOOD PRESSURE DIASTOLIC ABNORMAL 4 0.0016
368 DRUG LEVEL DECREASED 16 0.0016
369 THYROID MASS 6 0.0016
370 BACK PAIN 360 0.0015
371 PNEUMONIA BACTERIAL 14 0.0015
372 DERMATITIS ALLERGIC 19 0.0015
373 UPPER LIMB FRACTURE 30 0.0015
374 ALCOHOL POISONING 4 0.0015
375 OVERDOSE 322 0.0015
376 PRODUCT SIZE ISSUE 8 0.0015
377 CLUMSINESS 4 0.0015
378 AORTIC STENOSIS 5 0.0014
379 THROMBOTIC THROMBOCYTOPENIC PURPURA 5 0.0014
380 HEPATOCELLULAR INJURY 20 0.0014
381 DIALYSIS 20 0.0014
382 NEUROLOGICAL SYMPTOM 8 0.0014
383 MOBILITY DECREASED 100 0.0014
384 TUBULOINTERSTITIAL NEPHRITIS 26 0.0014
385 HEPATITIS ACUTE 9 0.0014
386 SOCIAL AVOIDANT BEHAVIOUR 8 0.0014
387 STAPHYLOCOCCAL BACTERAEMIA 6 0.0014
388 ABNORMAL DREAMS 38 0.0014
389 PYREXIA 475 0.0014
390 RENAL DISORDER 63 0.0014
391 CYTOMEGALOVIRUS VIRAEMIA 6 0.0013
392 NERVOUS SYSTEM DISORDER 42 0.0013
393 POLLAKIURIA 56 0.0013
394 ABNORMAL FAECES 11 0.0013
395 RETINOPATHY 5 0.0013
396 DRUG-INDUCED LIVER INJURY 42 0.0013
397 HYPERTHYROIDISM 19 0.0013
398 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 5 0.0013
399 SPINAL FRACTURE 26 0.0013
400 CIRCULATORY COLLAPSE 22 0.0013
401 FAMILY STRESS 4 0.0013
402 RHINOVIRUS INFECTION 5 0.0013
403 CHROMATURIA 29 0.0013
404 DISSEMINATED INTRAVASCULAR COAGULATION 18 0.0013
405 OSTEOARTHRITIS 54 0.0013
406 NAIL DISCOLOURATION 5 0.0013
407 MULTIPLE INJURIES 8 0.0013
408 CYTOMEGALOVIRUS INFECTION 21 0.0013
409 OESOPHAGEAL CANDIDIASIS 5 0.0013
410 POLYNEUROPATHY 15 0.0013
411 AZOTAEMIA 5 0.0013
412 CUSHINGOID 4 0.0012
413 RASH VESICULAR 6 0.0012
414 BONE MARROW FAILURE 25 0.0012
415 HORMONE LEVEL ABNORMAL 6 0.0012
416 HAEMOLYTIC ANAEMIA 11 0.0012
417 CONSTIPATION 267 0.0012
418 BREAST ENLARGEMENT 4 0.0012
419 CORONAVIRUS INFECTION 8 0.0012
420 HYPERKALAEMIA 42 0.0012
421 BLOOD TRIGLYCERIDES INCREASED 21 0.0012
422 METABOLIC ACIDOSIS 38 0.0012
423 RASH 518 0.0012
424 DRUG TOLERANCE 6 0.0012
425 INTERVERTEBRAL DISC DISORDER 5 0.0012
426 PRODUCT DOSE OMISSION ISSUE 344 0.0012
427 CAROTID ARTERY STENOSIS 4 0.0011
428 FOLLICULITIS 12 0.0011
429 ERYTHEMA 235 0.0011
430 HALLUCINATION, AUDITORY 18 0.0011
431 AGRANULOCYTOSIS 21 0.0011
432 SUICIDAL IDEATION 103 0.0011
433 HAEMORRHAGIC DIATHESIS 4 0.0011
434 TRANSPLANT REJECTION 9 0.0011
435 HYPONATRAEMIA 63 0.0011
436 GOUT 20 0.0011
437 GAIT DISTURBANCE 212 0.0011
438 DERMATITIS BULLOUS 8 0.0011
439 BIPOLAR DISORDER 12 0.0011
440 NIGHTMARE 38 0.0011
441 HEPATIC FAILURE 33 0.0011
442 HEPATITIS 28 0.0011
443 BLOOD PHOSPHORUS DECREASED 4 0.0011
444 HYPOPHOSPHATAEMIA 8 0.0011
445 RASH MACULO-PAPULAR 24 0.0011
446 HOSPITALISATION 164 0.0011
447 INTERVERTEBRAL DISC PROTRUSION 23 0.0011
448 CORONARY ARTERY BYPASS 6 0.0010
449 PYELONEPHRITIS 9 0.0010
450 DIFFUSE LARGE B-CELL LYMPHOMA 8 0.0010
451 LOW DENSITY LIPOPROTEIN INCREASED 8 0.0010
452 DYSURIA 38 0.0010
453 SPINAL PAIN 12 0.0010
454 HEPATIC CYTOLYSIS 13 0.0010
455 LIVER INJURY 25 0.0010
456 LIVER DISORDER 45 0.0010
457 DERMATITIS EXFOLIATIVE 5 0.0010
458 TOXIC ENCEPHALOPATHY 5 0.0010
459 PANCYTOPENIA 55 0.0010
460 NEUTROPENIC SEPSIS 7 0.0010
461 FEMORAL NECK FRACTURE 5 0.0010
462 DRUG DIVERSION 6 0.0010
463 DIABETES MELLITUS 74 0.0010
464 HEADACHE 606 0.0010
465 CONGESTIVE CARDIOMYOPATHY 4 0.0010
466 HALLUCINATIONS, MIXED 4 0.0010
467 PRODUCT DOSE OMISSION 62 0.0009
468 BLOOD LACTIC ACID INCREASED 5 0.0009
469 PSYCHOTIC DISORDER 28 0.0009
470 SKIN LESION 26 0.0009
471 TRANSAMINASES INCREASED 21 0.0009
472 ABSCESS LIMB 4 0.0009
473 HYDRONEPHROSIS 7 0.0009
474 PANIC ATTACK 34 0.0009
475 ATAXIA 11 0.0009
476 STRESS FRACTURE 5 0.0009
477 CARDIAC MURMUR 8 0.0009
478 HERPES SIMPLEX 6 0.0009
479 BONE PAIN 54 0.0009
480 MULTIPLE ORGAN DYSFUNCTION SYNDROME 26 0.0009
481 ACUTE RESPIRATORY DISTRESS SYNDROME 16 0.0009
482 DENTAL CARIES 10 0.0009
483 CATHETERISATION CARDIAC 4 0.0009
484 MENINGITIS 6 0.0009
485 LIVER FUNCTION TEST ABNORMAL 26 0.0009
486 UPPER GASTROINTESTINAL HAEMORRHAGE 15 0.0009
487 BLOOD BILIRUBIN INCREASED 24 0.0009
488 POSTOPERATIVE WOUND INFECTION 6 0.0009
489 CANDIDA INFECTION 15 0.0009
490 BLOOD ALKALINE PHOSPHATASE INCREASED 22 0.0009
491 ACUTE HEPATIC FAILURE 12 0.0009
492 BONE DISORDER 16 0.0009
493 NEPHROTIC SYNDROME 6 0.0009
494 TEMPERATURE INTOLERANCE 9 0.0009
495 HERPES VIRUS INFECTION 5 0.0009
496 BLOOD CHOLESTEROL ABNORMAL 4 0.0009
497 FEELING OF DESPAIR 4 0.0009
498 RIGHT VENTRICULAR FAILURE 6 0.0009
499 UPPER-AIRWAY COUGH SYNDROME 7 0.0008
500 LYMPHADENOPATHY 30 0.0008
501 RHABDOMYOLYSIS 35 0.0008
502 GRAFT VERSUS HOST DISEASE 6 0.0008
503 FATIGUE 649 0.0008
504 ANAEMIA 158 0.0008
505 INGUINAL HERNIA 5 0.0008
506 MAJOR DEPRESSION 6 0.0008
507 UTERINE LEIOMYOMA 6 0.0008
508 THERAPY CHANGE 8 0.0008
509 PANCREATITIS 43 0.0008
510 DRUG INTERACTION 129 0.0008
511 HYPERCALCAEMIA 10 0.0008
512 PIGMENTATION DISORDER 5 0.0008
513 NEPHROLITHIASIS 37 0.0008
514 MENTAL DISORDER 35 0.0008
515 BRAIN INJURY 8 0.0008
516 PAROSMIA 6 0.0008
517 DEPRESSED MOOD 42 0.0008
518 TOXIC SKIN ERUPTION 8 0.0008
519 DYSPHORIA 4 0.0008
520 INSOMNIA 209 0.0008
521 ENDOCARDITIS 4 0.0008
522 LABORATORY TEST ABNORMAL 23 0.0008
523 CEREBRAL ISCHAEMIA 4 0.0008
524 WEIGHT INCREASED 174 0.0008
525 CAESAREAN SECTION 9 0.0008
526 PRODUCT PREPARATION ISSUE 5 0.0008
527 PULMONARY ARTERIAL HYPERTENSION 11 0.0008
528 WALKING AID USER 5 0.0008
529 DYSPHAGIA 71 0.0007
530 OBSESSIVE-COMPULSIVE DISORDER 6 0.0007
531 HEPATIC CIRRHOSIS 14 0.0007
532 NOCTURIA 9 0.0007
533 BLOOD URINE PRESENT 14 0.0007
534 GENERAL PHYSICAL CONDITION ABNORMAL 5 0.0007
535 CEREBRAL INFARCTION 18 0.0007
536 MUSCULOSKELETAL DISORDER 14 0.0007
537 MATERNAL EXPOSURE BEFORE PREGNANCY 5 0.0007
538 HYPERAESTHESIA 6 0.0007
539 INJECTION SITE NODULE 8 0.0007
540 GENERAL PHYSICAL HEALTH DETERIORATION 84 0.0007
541 HYPERCHOLESTEROLAEMIA 7 0.0007
542 ENCEPHALITIS 5 0.0007
543 SLEEP DISORDER 51 0.0007
544 VENTRICULAR FIBRILLATION 8 0.0007
545 HYPERTENSIVE CRISIS 8 0.0007
546 GAIT INABILITY 24 0.0007
547 NEUROPATHY PERIPHERAL 68 0.0007
548 GLYCOSYLATED HAEMOGLOBIN INCREASED 18 0.0007
549 LYMPHOPENIA 10 0.0007
550 DISTURBANCE IN ATTENTION 38 0.0007
551 PARALYSIS 10 0.0007
552 ORAL CANDIDIASIS 9 0.0007
553 PSYCHIATRIC SYMPTOM 5 0.0007
554 GAMMA-GLUTAMYLTRANSFERASE INCREASED 15 0.0007
555 STEVENS-JOHNSON SYNDROME 15 0.0007
556 FEELING DRUNK 5 0.0007
557 OFF LABEL USE 589 0.0007
558 PRODUCT COMPLAINT 17 0.0007
559 HAEMARTHROSIS 6 0.0007
560 FEAR 18 0.0007
561 ERECTILE DYSFUNCTION 17 0.0007
562 NEOPLASM PROGRESSION 23 0.0007
563 HYPERGLYCAEMIA 24 0.0007
564 RASH GENERALISED 17 0.0007
565 DISORIENTATION 26 0.0007
566 HYPERTHERMIA 5 0.0007
567 LIPASE INCREASED 5 0.0007
568 MATERNAL DRUGS AFFECTING FOETUS 5 0.0007
569 LIVER FUNCTION TEST INCREASED 14 0.0007
570 LACTIC ACIDOSIS 21 0.0006
571 ALTERED STATE OF CONSCIOUSNESS 14 0.0006
572 PHARYNGITIS 8 0.0006
573 CYST 8 0.0006
574 DELUSION 10 0.0006
575 PELVIC FRACTURE 5 0.0006
576 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 11 0.0006
577 FLANK PAIN 6 0.0006
578 PARANOIA 11 0.0006
579 ARTERIOSCLEROSIS 6 0.0006
580 ALANINE AMINOTRANSFERASE INCREASED 39 0.0006
581 MUSCLE ATROPHY 8 0.0006
582 ANGINA PECTORIS 18 0.0006
583 SENSORY DISTURBANCE 10 0.0006
584 DIZZINESS POSTURAL 6 0.0006
585 FEMUR FRACTURE 19 0.0006
586 ASTHENIA 229 0.0006
587 DISABILITY 12 0.0006
588 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
589 ACUTE CORONARY SYNDROME 5 0.0006
590 HYPOXIA 21 0.0006
591 BRONCHIECTASIS 4 0.0006
592 ILL-DEFINED DISORDER 36 0.0006
593 HEPATIC STEATOSIS 11 0.0006
594 TENDONITIS 9 0.0006
595 ASCITES 17 0.0006
596 MUSCLE STRAIN 5 0.0006
597 SUICIDE ATTEMPT 35 0.0006
598 ACUTE MYOCARDIAL INFARCTION 17 0.0006
599 SLEEP APNOEA SYNDROME 11 0.0006
600 RESPIRATORY TRACT INFECTION 15 0.0006
601 CARPAL TUNNEL SYNDROME 8 0.0006
602 SCRATCH 6 0.0006
603 BLOOD LACTATE DEHYDROGENASE INCREASED 9 0.0006
604 PRODUCT COMMUNICATION ISSUE 5 0.0006
605 PURPURA 5 0.0006
606 THERAPY CESSATION 29 0.0006
607 TOOTH EXTRACTION 7 0.0006
608 PNEUMONIA ASPIRATION 14 0.0006
609 NIGHT SWEATS 18 0.0006
610 LOSS OF LIBIDO 5 0.0006
611 OROPHARYNGEAL DISCOMFORT 5 0.0006
612 HYPOKINESIA 8 0.0006
613 FAECES SOFT 4 0.0005
614 ASPARTATE AMINOTRANSFERASE INCREASED 29 0.0005
615 DRUG LEVEL INCREASED 9 0.0005
616 HYPOKALAEMIA 25 0.0005
617 FOOT DEFORMITY 6 0.0005
618 MYALGIA 92 0.0005
619 SQUAMOUS CELL CARCINOMA 5 0.0005
620 HALLUCINATION 40 0.0005
621 APHASIA 16 0.0005
622 MYOCARDIAL ISCHAEMIA 6 0.0005
623 TOXIC EPIDERMAL NECROLYSIS 8 0.0005
624 INTENTIONAL DOSE OMISSION 15 0.0005
625 NEOPLASM MALIGNANT 35 0.0005
626 AMNESIA 34 0.0005
627 TINNITUS 24 0.0005
628 EOSINOPHILIA 9 0.0005
629 SEXUAL DYSFUNCTION 6 0.0005
630 DIABETES MELLITUS INADEQUATE CONTROL 9 0.0005
631 DRUG ERUPTION 9 0.0005
632 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 13 0.0005
633 PRODUCT DISPENSING ERROR 11 0.0005
634 THIRST 9 0.0005
635 BLOOD DISORDER 4 0.0005
636 BLOOD POTASSIUM INCREASED 8 0.0005
637 DEATH 421 0.0005
638 CARDIOMEGALY 6 0.0005
639 INJECTION SITE MASS 18 0.0005
640 HELICOBACTER INFECTION 5 0.0005
641 MANIA 8 0.0005
642 ILEUS 6 0.0005
643 PSYCHOMOTOR HYPERACTIVITY 8 0.0005
644 EYE DISCHARGE 5 0.0005
645 HEMIPLEGIA 4 0.0005
646 PRODUCT STORAGE ERROR 42 0.0005
647 OEDEMA 26 0.0005
648 DYSPNOEA EXERTIONAL 18 0.0005
649 ARTHRALGIA 198 0.0005
650 SEIZURE 55 0.0005
651 PERICARDIAL EFFUSION 11 0.0005
652 JOINT DISLOCATION 5 0.0005
653 GASTRIC DISORDER 16 0.0005
654 SURGERY 27 0.0005
655 CEREBROVASCULAR ACCIDENT 78 0.0005
656 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 24 0.0005
657 BACK INJURY 5 0.0005
658 MENORRHAGIA 9 0.0005
659 DRUG DISPENSING ERROR 7 0.0005
660 INSURANCE ISSUE 7 0.0005
661 GYNAECOMASTIA 14 0.0005
662 PRESCRIBED UNDERDOSE 9 0.0005
663 JOINT RANGE OF MOTION DECREASED 6 0.0004
664 BRAIN FOG 7 0.0004
665 PANCREATITIS ACUTE 10 0.0004
666 ANGER 15 0.0004
667 RESTLESSNESS 16 0.0004
668 CARDIAC FAILURE 35 0.0004
669 CONDITION AGGRAVATED 132 0.0004
670 DELIRIUM 15 0.0004
671 HYPOPHAGIA 11 0.0004
672 ABDOMINAL PAIN 99 0.0004
673 PRODUCT DOSE OMISSION IN ERROR 12 0.0004
674 GENERALISED TONIC-CLONIC SEIZURE 7 0.0004
675 EATING DISORDER 9 0.0004
676 SEPSIS 47 0.0004
677 DISEASE RECURRENCE 20 0.0004
678 CEREBRAL HAEMORRHAGE 15 0.0004
679 HYPERSOMNIA 12 0.0004
680 POOR QUALITY SLEEP 9 0.0004
681 GASTRITIS 11 0.0004
682 BLINDNESS 17 0.0004
683 AFFECT LABILITY 4 0.0004
684 FAECES DISCOLOURED 9 0.0004
685 NAUSEA 327 0.0004
686 CRYING 15 0.0004
687 ADRENAL INSUFFICIENCY 5 0.0004
688 SCHIZOPHRENIA 5 0.0004
689 ORAL HERPES 8 0.0004
690 KIDNEY INFECTION 8 0.0004
691 HYPOTHYROIDISM 13 0.0004
692 LIMB INJURY 11 0.0004
693 DEPRESSED LEVEL OF CONSCIOUSNESS 16 0.0004
694 RASH PAPULAR 9 0.0004
695 BRAIN OEDEMA 5 0.0004
696 NEUTROPHIL COUNT DECREASED 16 0.0004
697 BODY TEMPERATURE INCREASED 8 0.0004
698 PHARYNGEAL OEDEMA 6 0.0004
699 INTENTIONAL PRODUCT USE ISSUE 34 0.0004
700 INFUSION SITE PAIN 5 0.0004
701 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 13 0.0004
702 ANGIOEDEMA 17 0.0004
703 INJURY 27 0.0004
704 PULMONARY HYPERTENSION 8 0.0004
705 DERMATITIS 8 0.0004
706 MUSCULOSKELETAL PAIN 20 0.0004
707 INCORRECT PRODUCT STORAGE 5 0.0004
708 BEDRIDDEN 5 0.0004
709 IMMUNE SYSTEM DISORDER 5 0.0004
710 TOOTH INFECTION 5 0.0004
711 DISCOMFORT 23 0.0004
712 PERIPHERAL SWELLING 58 0.0004
713 DYSARTHRIA 14 0.0004
714 WEIGHT DECREASED 103 0.0004
715 PARAESTHESIA 58 0.0004
716 SEPTIC SHOCK 16 0.0004
717 PRODUCT PRESCRIBING ISSUE 8 0.0004
718 MOOD ALTERED 10 0.0004
719 ENCEPHALOPATHY 9 0.0004
720 INCREASED APPETITE 7 0.0004
721 CENTRAL NERVOUS SYSTEM LESION 5 0.0004
722 STAPHYLOCOCCAL INFECTION 12 0.0004
723 MALAISE 159 0.0004
724 RESPIRATORY DISTRESS 10 0.0004
725 VISUAL ACUITY REDUCED 12 0.0004
726 NEUTROPENIA 49 0.0004
727 EPILEPSY 11 0.0004
728 PNEUMONIA 116 0.0004
729 NECK PAIN 20 0.0004
730 CELLULITIS 18 0.0004
731 SNEEZING 8 0.0004
732 TYPE 2 DIABETES MELLITUS 12 0.0004
733 ADVERSE DRUG REACTION 32 0.0004
734 FACE OEDEMA 6 0.0004
735 HAEMATEMESIS 9 0.0004
736 SKIN REACTION 5 0.0004
737 BLOOD PRESSURE ABNORMAL 7 0.0004
738 DERMATITIS CONTACT 4 0.0004
739 CHOLECYSTECTOMY 4 0.0003
740 DIARRHOEA 226 0.0003
741 MYOCARDIAL INFARCTION 61 0.0003
742 MUSCULOSKELETAL DISCOMFORT 6 0.0003
743 PAIN IN EXTREMITY 102 0.0003
744 VERTIGO 21 0.0003
745 ELECTROLYTE IMBALANCE 4 0.0003
746 CARDIAC DISORDER 32 0.0003
747 AGGRESSION 17 0.0003
748 CARDIOMYOPATHY 5 0.0003
749 SWELLING FACE 22 0.0003
750 GALLBLADDER DISORDER 6 0.0003
751 ACCIDENT 4 0.0003
752 THROAT TIGHTNESS 9 0.0003
753 HYPOAESTHESIA ORAL 5 0.0003
754 TOOTHACHE 6 0.0003
755 DRUG INEFFECTIVE 434 0.0003
756 PRESYNCOPE 8 0.0003
757 MEMORY IMPAIRMENT 45 0.0003
758 HYPOAESTHESIA 49 0.0003
759 GASTROINTESTINAL DISORDER 29 0.0003
760 OSTEONECROSIS OF JAW 8 0.0003
761 LIMB DISCOMFORT 10 0.0003
762 EYE SWELLING 12 0.0003
763 BACTERIAL INFECTION 6 0.0003
764 LOSS OF CONSCIOUSNESS 41 0.0003
765 PHOTOPHOBIA 6 0.0003
766 ABDOMINAL DISTENSION 33 0.0003
767 PNEUMOTHORAX 5 0.0003
768 DYSPEPSIA 31 0.0003
769 FEELING JITTERY 6 0.0003
770 TOOTH DISORDER 7 0.0003
771 DRUG DOSE OMISSION 52 0.0003
772 ULCER 5 0.0003
773 OROPHARYNGEAL PAIN 29 0.0003
774 ALOPECIA 61 0.0003
775 HERNIA 6 0.0003
776 INFLAMMATION 16 0.0003
777 DYSPNOEA 175 0.0003
778 PRURITUS 118 0.0003
779 ARTHROPATHY 17 0.0003
780 SPEECH DISORDER 16 0.0003
781 JOINT STIFFNESS 8 0.0003
782 C-REACTIVE PROTEIN INCREASED 11 0.0003
783 VOMITING 142 0.0003
784 PREGNANCY 6 0.0003
785 IRRITABILITY 18 0.0003
786 THROMBOSIS 24 0.0003
787 SOMNOLENCE 60 0.0003
788 PRODUCTIVE COUGH 14 0.0003
789 GINGIVAL BLEEDING 4 0.0003
790 DECREASED APPETITE 68 0.0003
791 BLOOD PRESSURE FLUCTUATION 7 0.0003
792 ABDOMINAL PAIN UPPER 60 0.0003
793 CONFUSIONAL STATE 47 0.0003
794 CHILLS 34 0.0003
795 DIZZINESS 144 0.0003
796 HYPOGLYCAEMIA 14 0.0003
797 URINARY TRACT INFECTION 49 0.0003
798 BLOOD TEST ABNORMAL 4 0.0003
799 FEELING ABNORMAL 68 0.0003
800 BRONCHITIS 21 0.0003
801 COLD SWEAT 5 0.0003
802 PAIN IN JAW 8 0.0003
803 FLATULENCE 16 0.0003
804 ILLNESS 29 0.0003
805 JOINT INJURY 6 0.0003
806 CHEST PAIN 52 0.0003
807 THERAPEUTIC RESPONSE DECREASED 17 0.0003
808 ABDOMINAL DISCOMFORT 47 0.0003
809 BLOOD CHOLESTEROL INCREASED 13 0.0003
810 HERPES ZOSTER 16 0.0003
811 ELECTROCARDIOGRAM QT PROLONGED 10 0.0003
812 BALANCE DISORDER 24 0.0003
813 PRURITUS GENERALISED 6 0.0003
814 DRUG EFFECT INCOMPLETE 10 0.0003
815 CHOLELITHIASIS 9 0.0003
816 PRODUCT USE IN UNAPPROVED INDICATION 68 0.0003
817 APATHY 4 0.0003
818 GASTROENTERITIS 4 0.0003
819 EYE DISORDER 9 0.0003
820 EXTRA DOSE ADMINISTERED 11 0.0003
821 BLOOD PRESSURE DECREASED 18 0.0003
822 LIP SWELLING 9 0.0003
823 HAEMATOMA 7 0.0003
824 CONJUNCTIVITIS 5 0.0003
825 DYSGEUSIA 20 0.0003
826 THINKING ABNORMAL 5 0.0003
827 HAEMORRHAGE 28 0.0003
828 SWELLING 25 0.0003
829 HEART RATE IRREGULAR 6 0.0003
830 BLOOD SODIUM DECREASED 5 0.0003
831 PALPITATIONS 31 0.0003
832 GASTRIC ULCER 5 0.0003
833 SKIN DISCOLOURATION 12 0.0003
834 ACUTE RESPIRATORY FAILURE 5 0.0003
835 DEVICE RELATED INFECTION 4 0.0003
836 SYNCOPE 26 0.0003
837 GLAUCOMA 5 0.0003
838 ERUCTATION 5 0.0003
839 RASH PRURITIC 14 0.0003
840 WHITE BLOOD CELL COUNT DECREASED 28 0.0003
841 RASH MACULAR 9 0.0003
842 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 6 0.0003
843 MUSCULAR WEAKNESS 29 0.0003
844 ARTHRITIS 20 0.0003
845 FALL 84 0.0003
846 PRODUCT PRESCRIBING ERROR 6 0.0003
847 THERAPY INTERRUPTED 18 0.0003
848 FEELING COLD 7 0.0003
849 COVID-19 44 0.0003
850 ADVERSE EVENT 23 0.0002
851 CONTUSION 24 0.0002
852 BLISTER 14 0.0002
853 MOVEMENT DISORDER 8 0.0002
854 OXYGEN SATURATION DECREASED 14 0.0002
855 NERVOUSNESS 13 0.0002
856 INTENTIONAL SELF-INJURY 5 0.0002
857 ATRIAL FIBRILLATION 24 0.0002
858 BACK DISORDER 4 0.0002
859 THERAPEUTIC RESPONSE UNEXPECTED 11 0.0002
860 URINARY RETENTION 8 0.0002
861 HALLUCINATION, VISUAL 5 0.0002
862 CARDIOVASCULAR DISORDER 6 0.0002
863 URINARY INCONTINENCE 7 0.0002
864 GASTROOESOPHAGEAL REFLUX DISEASE 19 0.0002
865 COUGH 66 0.0002
866 HAEMATURIA 8 0.0002
867 SKIN ULCER 6 0.0002
868 CORONARY ARTERY DISEASE 7 0.0002
869 DEEP VEIN THROMBOSIS 15 0.0002
870 EYE PAIN 13 0.0002
871 HEAD DISCOMFORT 4 0.0002
872 PLATELET COUNT DECREASED 24 0.0002
873 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 16 0.0002
874 CHEST DISCOMFORT 23 0.0002
875 DRY EYE 11 0.0002
876 MOOD SWINGS 7 0.0002
877 TOXICITY TO VARIOUS AGENTS 37 0.0002
878 LUNG NEOPLASM MALIGNANT 9 0.0002
879 SHOCK 5 0.0002
880 MENTAL STATUS CHANGES 6 0.0002
881 OEDEMA PERIPHERAL 26 0.0002
882 FEELING HOT 13 0.0002
883 HEART RATE INCREASED 21 0.0002
884 DEHYDRATION 28 0.0002
885 LETHARGY 12 0.0002
886 EYE IRRITATION 12 0.0002
887 DIABETIC KETOACIDOSIS 5 0.0002
888 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
889 BLOOD GLUCOSE INCREASED 39 0.0002
890 MENTAL IMPAIRMENT 5 0.0002
891 NEURALGIA 5 0.0002
892 ABNORMAL BEHAVIOUR 8 0.0002
893 CATARACT 12 0.0002
894 SKIN EXFOLIATION 17 0.0002
895 THROAT IRRITATION 9 0.0002
896 LOWER RESPIRATORY TRACT INFECTION 9 0.0002
897 STOMATITIS 12 0.0002
898 ABDOMINAL PAIN LOWER 5 0.0002
899 MUSCLE SPASMS 36 0.0002
900 INFLUENZA LIKE ILLNESS 16 0.0002
901 CARDIAC ARREST 16 0.0002
902 UNRESPONSIVE TO STIMULI 5 0.0002
903 DIPLOPIA 5 0.0002
904 DRUG ABUSE 16 0.0002
905 COMPLETED SUICIDE 16 0.0002
906 DEAFNESS 5 0.0002
907 ECZEMA 10 0.0002
908 AGITATION 14 0.0002
909 BRADYCARDIA 10 0.0002
910 DYSPHONIA 11 0.0002
911 HAEMOPTYSIS 5 0.0002
912 DEMENTIA 5 0.0002
913 PULMONARY OEDEMA 8 0.0002
914 EYE PRURITUS 6 0.0002
915 TREMOR 29 0.0002
916 CARDIAC FAILURE CONGESTIVE 14 0.0002
917 DYSKINESIA 7 0.0002
918 INTENTIONAL OVERDOSE 11 0.0002
919 INFLUENZA 19 0.0002
920 RHINORRHOEA 11 0.0002
921 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 34 0.0002
922 ROAD TRAFFIC ACCIDENT 7 0.0002
923 RESPIRATORY DISORDER 5 0.0002
924 SINUSITIS 17 0.0002
925 INTERSTITIAL LUNG DISEASE 8 0.0002
926 RESPIRATORY FAILURE 12 0.0002
927 LUNG DISORDER 8 0.0002
928 HYPOACUSIS 7 0.0002
929 EMOTIONAL DISORDER 5 0.0002
930 EXTRAPYRAMIDAL DISORDER 4 0.0002
931 EPISTAXIS 12 0.0002
932 SWOLLEN TONGUE 5 0.0002
933 MUSCULOSKELETAL STIFFNESS 14 0.0002
934 UNEVALUABLE EVENT 12 0.0002
935 GASTRIC CANCER 4 0.0002
936 NASOPHARYNGITIS 29 0.0002
937 PRODUCT SUBSTITUTION ISSUE 9 0.0002
938 THERAPEUTIC PRODUCT EFFECT DECREASED 7 0.0002
939 GASTROINTESTINAL HAEMORRHAGE 13 0.0002
940 VISUAL IMPAIRMENT 19 0.0002
941 NASAL CONGESTION 9 0.0002
942 VISION BLURRED 21 0.0002
943 UNDERDOSE 11 0.0002
944 SKIN DISORDER 5 0.0001
945 COGNITIVE DISORDER 7 0.0001
946 FREQUENT BOWEL MOVEMENTS 4 0.0001
947 DRY MOUTH 12 0.0001
948 OCULAR HYPERAEMIA 7 0.0001
949 TACHYCARDIA 13 0.0001
950 HAEMOGLOBIN DECREASED 15 0.0001
951 BLOOD GLUCOSE DECREASED 7 0.0001
952 HAEMATOCHEZIA 8 0.0001
953 HYPOTENSION 29 0.0001
954 BLOOD PRESSURE INCREASED 22 0.0001
955 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 25 0.0001
956 NO ADVERSE EVENT 25 0.0001
957 INJECTION SITE BRUISING 11 0.0001
958 URTICARIA 23 0.0001
959 PROSTATE CANCER 11 0.0001
960 THERAPY NON-RESPONDER 6 0.0001
961 BLOOD POTASSIUM DECREASED 4 0.0001
962 HOT FLUSH 10 0.0001
963 INTESTINAL OBSTRUCTION 5 0.0001
964 PLEURAL EFFUSION 8 0.0001
965 HEAD INJURY 4 0.0001
966 RENAL CANCER 6 0.0001
967 MEDICATION ERROR 7 0.0001
968 MIGRAINE 12 0.0001
969 DISEASE PROGRESSION 14 0.0001
970 INCORRECT DOSE ADMINISTERED 27 0.0001
971 VAGINAL HAEMORRHAGE 5 0.0001
972 HEART RATE DECREASED 4 0.0001
973 DRUG EFFECT DECREASED 6 0.0001
974 ACCIDENTAL OVERDOSE 4 0.0001
975 ACNE 8 0.0001
976 COMA 5 0.0001
977 CARDIO-RESPIRATORY ARREST 4 0.0001
978 CONVULSION 5 0.0001
979 BURNING SENSATION 6 0.0001
980 FLUSHING 8 0.0001
981 PULMONARY EMBOLISM 7 0.0001
982 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
983 INJECTION SITE REACTION 5 0.0001
984 INJECTION SITE PAIN 22 0.0001
985 INJECTION SITE HAEMORRHAGE 5 0.0001
986 FEBRILE NEUTROPENIA 4 0.0001
987 PRODUCT QUALITY ISSUE 7 0.0001
988 MALIGNANT NEOPLASM PROGRESSION 5 0.0000
989 DRUG WITHDRAWAL SYNDROME 4 0.0000
990 INJECTION SITE ERYTHEMA 5 0.0000
991 DRY SKIN 5 0.0000
992 DRUG DEPENDENCE 6 0.0000